Acute HIV infection
Information
- Disease name
- Acute HIV infection
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03711253 | Active, not recruiting | Phase 4 | Empiric Treatment for Acute HIV in the ED | October 14, 2019 | June 1, 2023 |
NCT03579381 | Completed | Specimen Repository for HIV Immunopathogenesis | July 31, 2017 | January 25, 2019 | |
NCT00734344 | Completed | N/A | Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection | September 2008 | September 2012 |
NCT00924898 | Completed | Phase 4 | Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805) | January 2005 | December 2013 |
NCT01154673 | Completed | Phase 2/Phase 3 | Effects of Intensive cART During Acute/Early HIV Infection | November 2011 | September 2014 |
NCT01197027 | Completed | Phase 3 | Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection | February 2010 | April 2012 |
NCT01369056 | Completed | N/A | HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence | July 2010 | December 2011 |
NCT01434706 | Completed | N/A | Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection | September 16, 2010 | April 7, 2015 |
NCT02170246 | Completed | Phase 1 | Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection | January 28, 2015 | June 13, 2018 |
NCT02614950 | Completed | N/A | Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection | February 2016 | December 2016 |
NCT02750059 | Completed | Phase 2 | Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis | January 2015 | February 2018 |
NCT02384395 | Completed | N/A | Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection | September 2015 | September 17, 2021 |
NCT02467439 | Completed | N/A | Acute Partner and Social Contact Referral: iKnow | June 2015 | May 2, 2019 |
NCT02470351 | Completed | Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS | January 2015 | March 2016 | |
NCT02475915 | Completed | Phase 1/Phase 2 | Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection | January 2015 | March 2016 |
NCT05719441 | Not yet recruiting | Phase 2 | A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission | June 15, 2024 | September 6, 2028 |
NCT05728996 | Recruiting | Netherlands Cohort Study on Acute HIV Infection | August 1, 2015 | August 1, 2028 | |
NCT00796146 | Recruiting | Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population | April 2009 | July 2033 | |
NCT00796263 | Recruiting | Phase 3 | Antiretroviral Therapy for Acute and Chronic HIV Infection | April 2009 | June 2033 |
NCT00855413 | Terminated | Phase 4 | HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine | March 2009 | November 2013 |
NCT02231281 | Unknown status | Phase 3 | Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults | August 2014 | December 2018 |
- MedGen concept unique identifier (MedGen Concept name)
- C0343752
- MedGen unique identifier (MedGen Concept name)
- 575808